Sign in

CIK 0001720580

  • Non-accelerated filer
  • Smaller reporting company

Adicet Bio, Inc.

Sign in to watch
Ticker
ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 26
Incorporated
DE
Entity type
Operating
EIN
813305277
Phone
+1 617-482-2333
Business address
131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
Former names
resTORbio, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-08-04 Galimi Francesco SVP & Chief Medical Officer Grant or award +16,000 75,917
2022-08-04 Galimi Francesco SVP & Chief Medical Officer Shares withheld for taxes −5,533 $18.25 $101K 70,384
2022-08-04 Aftab Blake Chief Scientific Officer Grant or award +16,000 54,967
2022-08-04 Aftab Blake Chief Scientific Officer Shares withheld for taxes −5,533 $18.25 $101K 49,434
2022-08-04 Harvey Brian Nicholas Chief Financial Officer Grant or award +16,000 70,608
2022-08-04 Harvey Brian Nicholas Chief Financial Officer Shares withheld for taxes −4,696 $18.25 $86K 65,912
2022-08-04 Healey Don Chief Technology Officer Grant or award +16,000 68,934
2022-08-04 Healey Don Chief Technology Officer Shares withheld for taxes −5,533 $18.25 $101K 63,401
2022-08-03 Aftab Blake Chief Scientific Officer Sale −6,968 $18.00 $125K 38,967
2022-08-01 Aftab Blake Chief Scientific Officer Sale −6,968 $16.64 $116K 45,935
2022-07-06 Schor Chen President & CEO Gift −53,424 96,000
2022-07-06 Schor Chen President & CEO Gift +53,424 143,260
2022-07-05 Aftab Blake Chief Scientific Officer Sale −1,363 $14.50 $20K 52,903
2022-06-02 GORDON CARL L Director Grant or award · Stock Option (Right to Buy) +18,500 18,500
2022-06-02 Sinclair Andrew Director Grant or award · Stock Option (Right to Buy) +18,500 18,500
2022-06-02 Sanna Bastiano Director Grant or award · Stock Option (Right to Buy) +18,500 18,500
2022-06-02 Kauffman Michael Director Grant or award · Stock Option (Right to Buy) +18,500 18,500
2022-06-02 Chodakewitz Jeffrey Director Grant or award · Stock Option (Right to Buy) +18,500 18,500
2022-06-02 DUBIN STEVE Director Grant or award · Stock Option (Right to Buy) +18,500 18,500
2022-06-02 Jakobovits Aya Director Grant or award · Stock Option (Right to Buy) +18,500 18,500

Page 17 of 24 · 478 trades